This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Kowa Company Limited. Active years: 2023-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2024
Title: Masatoshi Ito: Innovator in Pemafibrate Therapy
Introduction
Masatoshi Ito is a notable inventor based in Chuo-ku, Japan. He has made significant contributions to the field of medicine, particularly in the development of dosing regimens for pemafibrate therapy. With a total of three patents to his name, Ito's work is focused on improving patient safety and treatment efficacy.
Latest Patents
Ito's latest patents revolve around the formulation of a medicament for safely treating patients in need of pemafibrate therapy. His innovations include methods to avoid or suspend the concomitant use of pemafibrate with certain inhibitors, which helps to suppress an increase in plasma concentration. This careful approach aims to enhance the safety and effectiveness of pemafibrate treatment for patients.
Career Highlights
Masatoshi Ito is currently associated with Kowa Company Limited, where he continues to advance his research and development efforts. His work has been instrumental in shaping the landscape of pemafibrate therapy, contributing to better treatment protocols for patients.
Collaborations
Ito collaborates with esteemed colleagues such as Ryu Oshima and Chisato Nagai. Their combined expertise fosters an environment of innovation and progress in the field of pharmaceutical development.
Conclusion
Masatoshi Ito's contributions to pemafibrate therapy exemplify the impact of dedicated inventors in the medical field. His innovative approaches and collaborative efforts continue to pave the way for safer and more effective treatments.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
